ARCA biopharma Announces Second Quarter 2015 Operating Results And Provides Update On Recent Accomplishments

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the quarter ended June 30, 2015, and provided an update on recent accomplishments.

Help employers find you! Check out all the jobs and post your resume.